Prostheses List Reforms – PwC Report on Reforms to the Prostheses List Part B – May 2023

Overview

We are seeking feedback from stakeholders on the PricewaterhouseCoopers' (PwC) report and recommendations on the proposed reforms to Part B of the Prescribed List of Benefits for Medical Devices and Human Tissue Products* (the PL), and the proposed restructure of Part B.

The report outlines a way forward agreed between the department and key stakeholders in terms of the new structure of Part B, and the listing process to be used for new products, and also includes amendments to hereco's proposed Part B restructure received from recent stakeholder consultations.

The report and proposed Part B restructure are open for consultation via an online survey and can be accessed using the link below.

We have written permission from PwC to publicly release the report.  Please refer to the report's 'Disclaimer' for further information on the intended use of this report.

*Please note: The PwC report was finalised in May 2023, prior to the following changes implemented on 1 July 2023:

• renaming of the Prostheses List to the Prescribed List of Benefits for Medical Devices and Human Tissue Products (the PL)
• commencement of the Medical Devices and Human Tissue Advisory Committee (MDHTAC), replacing the Prostheses List Advisory Committee (PLAC)
• commencement of Expert Clinical Advisory Groups (ECAGs), replacing the Clinical Advisory Groups (CAGs)
• renaming of the Private Health Insurance (Prostheses) Rules to the Private Health Insurance (Medical Devices and Human Tissue Products) Rules (No.1) 2023

Why your views matter

Your feedback will help inform improvements to Part B of the PL.

Please download the documents via the below links to complete the survey, noting that answers are limited to 800 words (approx 1600 characters) for each recommendation.

This consultation closes on 6 October 2023.

Late submissions and/or requests for an extension will not be accepted.